American Morning
Tune in at 6am Eastern for all the news you need to start your day.
July 13th, 2010
09:47 AM ET
FDA Avandia hearings panel decides fate of diabetes drug
An FDA panel is will begin hearings on Avandia today. The drug that's safety has been questioned since 2007 and could be pulled from the market. Steven Nissen has authored a study finding it could increase the risk of heart attacks. He spoke to CNN's Kiran Chetry Tuesday.
About this Show
Welcome to the American Morning blog where you can get daily news updates from American Morning's reporters and producers. Join us for "the most news in the morning," weekdays from 6-9 a.m. ET, only on CNN.
On Twitter
This is amazing for us, Meredith! twitter.com/mbennettsmith/…
Derek Chauvin's trial is a chance for the justice system to prove it can actually work msnbc.com/opinion/derek-…
RT @ConstitutionCtr: #WomensHistoryMonth is a time to reflect on the women who have shaped America’s story.@RosenJeffreyey an@MSNBCBC's @Al…
RT @centralbanks_: The Exchange | Conversations for a Better Future One-on-one conversation with IMF Chief Kristalina Georgieva and Micros…
RT @ConstitutionCtr: #WomensHistoryMonth is a time to reflect on the women who have shaped America’s story.@RosenJeffreyey an@MSNBCBC's @Al…
It’s important for people to have an elected official who not only understands their platform, but one who is alsotwitter.com/i/web/status/1…2Zk1
Other drugs have been pulled for links with cardiovascular events- why not avandia? I would not want to take it, even if prescribed by a board certified endocrinologist. There are plenty of other options.